| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/25/2007 | WO2006102345A3 Methods and systems for operating an aerosol generator |
| 01/25/2007 | WO2006080009A3 Implantable bioreactors and uses thereof |
| 01/25/2007 | WO2006078948A3 Stable pharmaceutical formulations of zonisamide and methods for their manufacture |
| 01/25/2007 | WO2006078699B1 Oral care compositions derived from the labiatae family |
| 01/25/2007 | WO2006072943A3 Nano- and mesosized particles comprising an inorganic core, process and applications thereof |
| 01/25/2007 | WO2006068899A3 Preserved ophthalmic compositions comprising aloe vera |
| 01/25/2007 | WO2006037089A3 Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| 01/25/2007 | WO2006030111A3 Biodegradable polymer microparticles |
| 01/25/2007 | WO2006027116A3 P277 peptide formulations or variants thereof having optimised stability |
| 01/25/2007 | WO2006000272A3 Device for the targeted release of substances in a cavity |
| 01/25/2007 | WO2005123043A3 Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
| 01/25/2007 | WO2005107710A3 Particles for the delivery of active agents |
| 01/25/2007 | WO2004047844A8 Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain |
| 01/25/2007 | US20070021735 Dual membrane electro-osmotic fluid delivery device |
| 01/25/2007 | US20070021734 Bioelectro-osmotic engine fluid delivery device |
| 01/25/2007 | US20070021733 Internal fluid connector |
| 01/25/2007 | US20070021717 Intradermal Delivery Device |
| 01/25/2007 | US20070021503 Ophthalmic fluid |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021438 Itraconazole solution |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/25/2007 | US20070021344 Stabilized teriparatide solutions |
| 01/25/2007 | US20070021343 preparing a sealed vial or sealed cartridge for storage stability, resist to oxidation and chemical; including BUFFER AND A POLYOL; MANNITOL, BUFFER OF AN ACETATE OR TARTRATE, M-CRESOL OR BENZYL ALCOHOL PRESERVATIVE; parathyroid hormone for treating osteoporosis |
| 01/25/2007 | US20070021338 Stabilised compositions of Factor VII |
| 01/25/2007 | US20070021333 Pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins |
| 01/25/2007 | US20070020339 Compositions and methods for controlling abuse of medications |
| 01/25/2007 | US20070020338 Fluid bed granulation process and apparatus |
| 01/25/2007 | US20070020337 Paclitaxel-based antitumor formulation |
| 01/25/2007 | US20070020336 Cyclodextrin nanotechnology for ophthalmic drug delivery |
| 01/25/2007 | US20070020335 Sustained release pharmaceutical compositions for highly water soluble drugs |
| 01/25/2007 | US20070020334 Benzimidazole formulation |
| 01/25/2007 | US20070020333 Controlled release of hypnotic agents |
| 01/25/2007 | US20070020331 Coated tablet with zero-order of near zero-order release kinetics |
| 01/25/2007 | US20070020329 Methods of formulating linezolid |
| 01/25/2007 | US20070020328 Probiotics as alternative medicines against infectious diseases |
| 01/25/2007 | US20070020327 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| 01/25/2007 | US20070020326 Drug delivery system and method |
| 01/25/2007 | US20070020323 Method and device for improving the permeability of the human skin |
| 01/25/2007 | US20070020322 Method for inhibiting the growth of antibiotic resistant of bacteria by using pentane-1, 5-diol |
| 01/25/2007 | US20070020317 Negative ionic silica gel composition and the process for producing the same |
| 01/25/2007 | US20070020316 Personal topical disinfectant device |
| 01/25/2007 | US20070020315 Tissue products having low stiffness and antimicrobial activity |
| 01/25/2007 | US20070020314 Adhesion inhibiting material for vertebral/spinal operation |
| 01/25/2007 | US20070020311 Medicament delivery device and a method of medicament delivery |
| 01/25/2007 | US20070020310 Self-assembled, micropatterned, and radio frequency (RF) shielded BioContainers |
| 01/25/2007 | US20070020300 Recreational water treatment employing singlet oxygen |
| 01/25/2007 | US20070020295 Controlled release neurotoxin system and method |
| 01/25/2007 | US20070020289 Preparations and processes for stabilizing biological materials by means of drying processes without freezing |
| 01/25/2007 | US20070020282 Monoglycerides; fatty acids; for parenteral or mucosal administration of antigens and/or vaccines to humans and animals |
| 01/25/2007 | US20070020255 Method of stabilizing antibody and stabilized solution-type antibody preparation |
| 01/25/2007 | US20070020254 Methods and compositions for treatment of inflammatory disease |
| 01/25/2007 | US20070020245 Composition for the treatment of arthrosis/arthritis, especially for treating joints |
| 01/25/2007 | US20070020244 Fiber constructs and process of fiber fabrication |
| 01/25/2007 | US20070020226 Polyacrylamide Hydrogel For The Treatment of Incontinence and Vesicouretal Reflux |
| 01/25/2007 | US20070020199 Dispersible macromolecule compositions and methods for their preparation and use |
| 01/25/2007 | US20070020198 inhalers used in the treatment of respiratory system disorders, such as chronic obstructive pulmonary disease and asthma |
| 01/25/2007 | US20070020197 Preparation of pharmaceutical compositions containing nanoparticles |
| 01/25/2007 | US20070020189 Method of delivering compositions to substrates |
| 01/25/2007 | US20070020188 Pharmaceutical formulation containing irritant |
| 01/25/2007 | US20070020187 Solid dosage formulations of narcotic drugs having improved buccal adsorption |
| 01/25/2007 | US20070020186 Solid dosage formulations of narcotic drugs having improved buccal adsorption |
| 01/25/2007 | US20070017513 Method and apparatus for dispensing inhalator medicament |
| 01/25/2007 | US20070017508 Methods for treating jaw pain |
| 01/25/2007 | DE102005035374A1 Nanohohlkapseln Nano hollow capsules |
| 01/25/2007 | DE102005031467A1 Emulgatorsystem, Emulsion und deren Verwendung Emulsifier, emulsion and the use thereof |
| 01/25/2007 | CA2838108A1 Sustained release of antiinfectives |
| 01/25/2007 | CA2658491A1 Membrane-translocating peptides |
| 01/25/2007 | CA2616156A1 Rh-epo nasal formulations with low sialic acid concentration for the treatment of diseases of the central nervous system |
| 01/25/2007 | CA2616091A1 Intermolecular association complex of a carrier and of an active principle |
| 01/25/2007 | CA2616081A1 Gastroretentive formulations and manufacturing process thereof |
| 01/25/2007 | CA2616012A1 Drug-containing coated fine particle for intrabuccally disintegrating preparation and method of producing the same |
| 01/25/2007 | CA2615745A1 Composition containing micronutrients with improved anti-oxidant activity and the use thereof |
| 01/25/2007 | CA2615744A1 Plexin d1 as a target for tumor diagnosis and therapy |
| 01/25/2007 | CA2615716A1 Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers |
| 01/25/2007 | CA2615629A1 Oral care composition |
| 01/25/2007 | CA2615552A1 Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent |
| 01/25/2007 | CA2615533A1 Oral, rapidly disintegrating film, which cannot be spat out, for a neuroleptic |
| 01/25/2007 | CA2615378A1 Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof |
| 01/25/2007 | CA2615370A1 Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders |
| 01/25/2007 | CA2615360A1 Formulation and method for administration of ophthalmologically active agents |
| 01/25/2007 | CA2614850A1 Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor |
| 01/25/2007 | CA2614764A1 Sustained release of antiinfectives |
| 01/25/2007 | CA2614664A1 Daily dosage regimen for treating diabetes, obesity,metabolic syndrome and polycystic ovary syndrome |
| 01/25/2007 | CA2614468A1 Novel granulation process and granulate produced therefrom |
| 01/25/2007 | CA2614187A1 Drospirenone containing transdermal drug delivery devices and methods of delivery thereof |
| 01/25/2007 | CA2614097A1 Polymer film for transdermal patches with pharmaceutical active |
| 01/25/2007 | CA2613178A1 Sustained release preparation |
| 01/25/2007 | CA2612960A1 Highly bioavailable oral delayed release dosage forms of o-desmethylvenlafaxine succinate |
| 01/25/2007 | CA2611938A1 Modified release ticlopidine compositions |
| 01/25/2007 | CA2607360A1 Solid dosage formulations of narcotic drugs having improved buccal adsorption |
| 01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
| 01/24/2007 | EP1745775A1 Gastroretentive formulations and manufacturing process thereof. |
| 01/24/2007 | EP1745774A2 Solid pharmaceutical dispersions with enhanced bioavailability |
| 01/24/2007 | EP1744789A1 Activatable particles, preparations and uses |
| 01/24/2007 | EP1744784A2 Formulations of anti-pain agents and methods of using the same |
| 01/24/2007 | EP1744783A1 Compositions comprising cells and magnetic materials for targeted delivery |
| 01/24/2007 | EP1744782A1 Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof |
| 01/24/2007 | EP1744771A2 Self assembled nanotubes and methods for preparing the same |
| 01/24/2007 | EP1744768A2 Peritoneal dialysis solution |
| 01/24/2007 | EP1744765A2 Materials for medical implants and occlusive devices |